arrow
S

Senzo Taguchi

department of radiation oncology
H指数:9
被引数:315

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytotoxic immune activity reflects a coordinated immune microenvironment and is associated with response to total neoadjuvant therapy in rectal cancer

细胞毒性免疫活性反映协调的免疫微环境,并与直肠癌中总新辅助治疗的应答相关

2026-08-180
PRE
Safety and Tolerability of Different Total Neoadjuvant Therapies in Patients With Locally Advanced Rectal Cancer

局部晚期直肠癌患者中不同总新辅助疗法的安全性与耐受性

2026-06-220
OAAI
Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER)

高风险中枢神经系统复发风险的初诊弥漫大B细胞淋巴瘤的pola-R-CHP/高剂量甲氨蝶呤/鞘内注射 vs. pola-R-CHP/鞘内注射的随机III期研究方案摘要:JCOG2201 (PREMIER)

2025-12-010
OA
Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis

局部晚期直肠癌总新辅助治疗方案对放疗诱导性淋巴细胞减少的影响:一项回顾性分析

2025-11-010
OA
Induction chemotherapy followed by long-course chemoradiotherapy versus short-course radiotherapy followed by consolidation chemotherapy for achieving complete response in patients with locally advanced rectal cancer: a propensity-score matching study

诱导化疗后行长程化放疗与短程放疗后行巩固化疗以实现局部晚期直肠癌患者完全缓解:一项倾向性评分匹配研究

2025-09-010
PRE
An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas

国际淋巴瘤放射肿瘤学组关于双侧惰性眼附属器淋巴瘤放射治疗的研究

2025-03-140
PRE
Number of Sites of Involvement Predicts Central Nervous System Relapse in Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma

累及部位数量可预测局限性结外自然杀伤/T细胞淋巴瘤患者的中枢神经系统复发。

BLOOD
IF23.1
2024-11-050
PRE
Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

比较侵袭性NK细胞白血病与晚期结外NK/T细胞淋巴瘤的临床特征及预后

BLOOD
IF23.1
2024-11-050
PRE
Interim endoscopic restaging after induction chemotherapy to predict complete response and survival after total neoadjuvant therapy in low rectal cancer: Ad-hoc analysis of the IMPACT trial

诱导化疗后内镜分期以预测低位直肠癌完全新辅助治疗后的完全应答和生存:IMPACT试验的专项分析

2024-09-010
PRE
ASO Visual Abstract: Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection in Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncological Outcomes-A Propensity Score-Matched Analysis
2023-04-280
PRE
Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched Analysis
2023-04-096
PRE
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma

结外自然杀伤/T细胞淋巴瘤的长期预后和中枢神经系统复发

2022-03-022
PRE
Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity
2022-03-016
PRE
Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer
2019-04-0832
PREAI